Assignee
NOBELPHARMA CO LTD
JP·7 granted patents·11 pending applications·1 citations·filing 2015–2025
Top patents by PatentIndex Score
18 records- 0164US2025032463A1Rapamycin-containing pharmaceutical compositionNOBELPHARMA CO LTD·Filed 2023·Application pending·0 cites
- 0260US10369159B2Estrogen receptor β partial agonist having estrogen receptor α inhibitory effect, and gynecological disease therapeutic agent using sameNOBELPHARMA CO LTD·Filed 2018·Granted Aug 6, 2019·0 cites·4 claims
- 0357US10357595B2Agent for regenerating tympanic membrane or external auditory canalNOBELPHARMA CO LTD·Filed 2018·Granted Jul 23, 2019·0 cites·20 claims
- 0457US2026000707A1Tablet with improved stabilityNOBELPHARMA CO LTD·Filed 2025·Application pending·0 cites
- 0553US10813765B2Voice disorder treatment tool and voice disorder treatment setNOBELPHARMA CO LTD·Filed 2016·Granted Oct 27, 2020·1 cites·9 claims
- 0653US2023293510A1Patch for alleviating or treating symptoms of neurodegenerative diseaseNOBELPHARMA CO LTD·Filed 2021·Application pending·0 cites
- 0752US2023016901A1Granule in which unpleasant taste is masked and method for producing granuleNOBELPHARMA CO LTD·Filed 2020·Application pending·0 cites
- 0850US2020330561A1Composition for treatment of facial nerve palsyNOBELPHARMA CO LTD·Filed 2019·Application pending·0 cites
- 0949US10117969B2Agent for regenerating tympanic membrane or external auditory canalNOBELPHARMA CO LTD·Filed 2015·Granted Nov 6, 2018·0 cites·5 claims
- 1048US2022160697A1Pharmaceutical composition having excellent drug absorption into the living body and excellent chemical stabilityNOBELPHARMA CO LTD·Filed 2020·Application pending·0 cites
- 1143US2023056335A1Topical formulation containing rapamycinNOBELPHARMA CO LTD·Filed 2021·Application pending·0 cites
- 1239US2021128529A1Drug containing pyrazolone derivativeNOBELPHARMA CO LTD·Filed 2018·Application pending·0 cites
- 1337US11517424B2Tool for molding dysphonia treatment tool, and method for bending front piece of dysphonia treatment toolNOBELPHARMA CO LTD·Filed 2018·Granted Dec 6, 2022·0 cites·15 claims
- 1437US2018200266A1ESTROGEN RECEPTOR Beta PARTIAL AGONIST HAVING ESTROGEN RECEPTOR Alpha INHIBITORY EFFECT, AND GYNECOLOGICAL DISEASE THERAPEUTIC AGENT USING SAMENOBELPHARMA CO LTD·Filed 2016·Application pending·0 cites
- 1536US2021236019A1Jig for measuring shape of thyroid cartilageNOBELPHARMA CO LTD·Filed 2019·Application pending·0 cites
- 1631US11051985B2Preparation jig for tympanic membrane regenerating agent and preparation vessel for tympanic membrane regenerating agentNOBELPHARMA CO LTD·Filed 2016·Granted Jul 6, 2021·0 cites·13 claims
- 1730US11523908B2Dysphonia treatment toolNOBELPHARMA CO LTD·Filed 2016·Granted Dec 13, 2022·0 cites·6 claims
- 1820US2020166507A1Measurement method and measurement kit for proteins related to genetic diseasesNOBELPHARMA CO LTD·Filed 2017·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →